Mar 31, 2023

Revolution Medicines Q1 2023 Earnings Report

Total Revenue
$7.01M
Previous year: $7.58M
-7.4%
EPS
-$0.72
Previous year: -$0.78
-7.7%
R&D Expenses
$68.9M
G&A Expenses
$13.2M
Gross Profit
$4.48M
Previous year: $5.29M
-15.3%
Cash and Equivalents
$427M
Previous year: $97.7M
+337.4%
Free Cash Flow
-$64.1M
Previous year: -$57M
+12.4%
Total Assets
$1.07B
Previous year: $683M
+57.2%

Revolution Medicines

Revolution Medicines